The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Zisman, A., Pantuck, A. J., Wieder, J., Chao, D. H., Dorey, F., Said, J. W., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.111 · Cited by 675
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
MOTZER, R. J., & RUSSO, P. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67889-5 · Cited by 603
Messing, E. M., Manola, J. B., Wilding, G., PROPERT, K. J., Fleischmann, J. D., Crawford, E. D., Pontes, J. E., Hahn, R. G., & Trump, D. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.005 · Cited by 309
RENAL CELL CARCINOMA: MANAGEMENT OF ADVANCED DISEASE
FIGLIN, R. A. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61897-4 · Cited by 266
Evaluation of the New Tumor, Nodes and Metastases Classification of Renal Cell Carcinoma
Hermanek, P., & Schrott, K. M. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39420-x · Cited by 142
Seliger, B., Hammers, S., Höhne, A., Zeidler, R., Knuth, A. K., Gerharz, C., & Huber, C. G. (1997) · PubMed · Cited by 65
Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies
Michael, A., & Pandha, H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01044-1 · Cited by 58
Gastl, G. A., Ebert, T., Finstad, C. L., et al. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66661-8 · Cited by 54
Cited by
Treatment of renal cell carcinoma: Current status and future directions
Barata, P. C., & Rini, B. I. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21411 · Cited by 831
Cancer immunotherapies: advances and bottlenecks
Rui, R., Zhou, L., & He, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212476 · Cited by 484
TLR agonists: our best frenemy in cancer immunotherapy
Kaczanowska, S., Joseph, A. M., & Davila, E. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012501 · Cited by 339
Wood, C., Srivastava, P., Bukowski, R., Lacombe, L., Gorelov, A. I., Gorelov, S., Mulders, P., Zielinski, H., Hoos, A., Teofilovici, F., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60697-2 · Cited by 332
Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy
Nikolouzakis, T. K., Chrysos, E., Docea, A. O., Fragkiadaki, P., Souglakos, J., Tsiaoussis, J., & Tsatsakis, A. (2024) · Cancers · doi:10.3390/cancers16111995 · Cited by 37
Metadata
- Authors
- Jocham, D., Richter, A., Hoffmann, L., Iwig, K., Fahlenkamp, D., Zakrzewski, G., Schmitt, E., Dannenberg, T., Lehmacher, W., von Wietersheim, J., & Doehn, C.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 363
- Issue
- 9409
- Pages
- 594-599
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2050181929
- Cited by
- 434
- References
- 12
- FWCI
- 33.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)15590-6
- The paper
- Jocham, D., Richter, A., Hoffmann, L., Iwig, K., Fahlenkamp, D., Zakrzewski, G., Schmitt, E., Dannenberg, T., Lehmacher, W., von Wietersheim, J., & Doehn, C. (2004). Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)15590-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
